
Oncology Today with Dr Neil Love
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab
16 min•16 november 2026
Om avsnittet
Featuring an interview with Dr Matthew Lunning, including the following topics:
- Tafasitamab for follicular lymphoma (0:00)
- frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)
Oncology Today with Dr Neil Love med Dr. Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.